Cardinal Health, Inc. $CAH Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC lessened its stake in Cardinal Health, Inc. (NYSE:CAH) by 87.5% in the first quarter, HoldingsChannel.com reports. The firm owned 1,428 shares of the company’s stock after selling 10,022 shares during the quarter. International Assets Investment Management LLC’s holdings in Cardinal Health were worth $303,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Nordea Investment Management AB grew its holdings in Cardinal Health by 328.3% in the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after purchasing an additional 494,731 shares during the last quarter. Procyon Advisors LLC raised its stake in shares of Cardinal Health by 78.7% during the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after buying an additional 7,499 shares during the last quarter. Kornitzer Capital Management Inc. KS raised its stake in shares of Cardinal Health by 100.8% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock worth $3,733,000 after buying an additional 9,120 shares during the last quarter. Swiss Life Asset Management Ltd boosted its position in shares of Cardinal Health by 73.3% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 76,736 shares of the company’s stock worth $12,044,000 after buying an additional 32,464 shares in the last quarter. Finally, Achmea Investment Management B.V. boosted its position in shares of Cardinal Health by 4.3% in the 3rd quarter. Achmea Investment Management B.V. now owns 203,341 shares of the company’s stock worth $31,917,000 after buying an additional 8,381 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 2.3%

Cardinal Health stock opened at $224.75 on Thursday. The stock has a 50-day moving average price of $214.48 and a 200 day moving average price of $213.51. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21. The stock has a market cap of $52.64 billion, a PE ratio of 34.37, a P/E/G ratio of 1.13 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.50%.

Analyst Ratings Changes

Several research firms have weighed in on CAH. William Blair began coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating for the company. Evercore reduced their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. TD Cowen raised their price objective on shares of Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Finally, Bank of America lifted their price objective on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $249.13.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.